Fingolimod Therapy in Early Multiple Sclerosis: An Efficacy Analysis of the TRANSFORMS and FREEDOMS Studies by Time Since First Symptom
Author:
Affiliation:
1. Department of Neurology; University of California Davis; Davis CA USA
2. Veteran's Affairs Northern California Health Care System; Mather CA USA
3. US Medical Unit; Novartis Pharmaceuticals Corporation; East Hanover NJ USA
Publisher
Wiley
Subject
Pharmacology (medical),Physiology (medical),Psychiatry and Mental health,Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/cns.12235/fullpdf
Reference23 articles.
1. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process;Confavreux;Brain,2003
2. The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability;Scalfari;Brain,2010
3. Impact of multiple sclerosis relapses on progression diminishes with time;Tremlett;Neurology,2009
4. The natural history of multiple sclerosis: a geographically based study. 2. predictive value of the early clinical course;Weinshenker;Brain,1989
5. Effect of relapses on development of residual deficit in multiple sclerosis;Lublin;Neurology,2003
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis;Cochrane Database of Systematic Reviews;2024-01-04
2. Exercise Therapy in Early Multiple Sclerosis Improves Physical Function But Not Cognition: Secondary Analyses From a Randomized Controlled Trial;Neurorehabilitation and Neural Repair;2023-03-10
3. Prediction in treatment outcomes in multiple sclerosis: challenges and recent advances;Expert Review of Clinical Immunology;2021-10-20
4. Is disease activity prior to fingolimod initiation predictive of response? Fingolimod as a “common” first line treatment;Revue Neurologique;2021-10
5. Safety and Efficacy of Fingolimod in Iranian Patients with Relapsing-remitting Multiple Sclerosis;Basic and Clinical Neuroscience Journal;2021-03-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3